drugs | Gerald R. Ford School of Public Policy
Tags

drugs

Showing 1 - 12 of 12 results
In the Media

Medicare drug price negotiations an important first step - Cohn

Sep 1, 2023 WNYC
Jonathan Cohn, WNYC: The immediate cause was an enactment of the Inflation Reduction Act, that big law that Biden and the Democrats passed last year. It's probably best known for its climate provisions. This is the law that puts all this money into...
In the Media

Ali on designating drug cartels as terrorist organizations

Mar 10, 2023 Texas Public Radio
Javed Ali, Texas Public Radio: "It's a complicated process for any organization to be designated by the United States as a foreign terrorist organization. The State Department and our government take the lead for that. If a designation were to...
In the Media

Ali: No authority to use military force to fight drug cartels

Mar 7, 2023 AFP
Javed Ali, AFP: "Unless this resolution or any similar one becomes law, there is currently no explicit legal authority that the president has that directly approves military operations against drug cartels in Mexico. (If there was an attack on US...

ACLU's Kary Moss renews call for civil asset forfeiture reform

Jun 29, 2015
Kary Moss has long advocated for reform to the state’s civil asset forfeiture laws. After years of lobbying and advocacy, she and other supporters may finally see changes to the controversial laws.The Senate is set to consider an eight-bill package,...
State & Hill

Polling parents on children's health

Dec 6, 2010
Want to know what the nation thinks about childhood obesity, bullying, or genetic risk testing? Ask Dr. Matthew Davis, an associate professor at the Ford School and the Medical School. As director of the C.S. Mott Children's Hospital National Poll...

Ford Policy Union: International drug treaties

Oct 9, 2013 1:30:42

A debate on international drug policy with leading experts Jeffrey Miron, senior lecturer and director of undergraduate studies in the Department of Economics at Harvard University, and Kevin Sabet, director of the Drug Policy Institute.